NEW ORLEANS, Louisiana, November 7 /PRNewswire/ --

- Residual Vascular Risk Reduction: The Global Call to Action

- Announcement of the Launch of the Residual Risk Reduction Initiative: R3i

KEY FACTS:

Residual Risk Reduction Initiative (R3i) calls for action to reduce the lipid related residual vascular risk unaddressed by current standards of care in millions of patients with heart disease and diabetes

WHERE:

Audubon Room, Ritz Carlton Hotel, 921 Canal Street, New Orleans, USA

WHEN:

Sunday 9 November 2008, 19:00-20:30 hrs CST (GMT- 6hrs)

WHAT:

Internationally recognized specialists from North America, Europe, Asia and Japan come together to launch the Residual Risk Reduction Initiative (R3i) - a unique global program to evaluate and to reduce the excess risk of myocardial infarction, stroke, kidney disease, loss of vision and non-traumatic limb amputation which exists in many patients with heart disease and diabetes despite optimal, currently available care.

To address these important issues, the R3i engages healthcare professionals in an innovative global initiative of academic research, education and advocacy.

WHO:

Professor Frank Sacks, Vice-President R3i, Department of Nutrition Harvard School of Public Medicine, Boston, MA, USA

Professor W.Virgil Brown, International Steering Committee R3i, Charles Howard Candler Professor of Medicine, Emory University, Chief of Medicine, Atlanta, GA, USA

Professor Michel Hermans, General Secretary R3i, Department of Endocrinology and Nutrition, Cliniques Universitaires St. Luc, Université Catholique de Louvain, Brussels, Belgium

For more information, or to arrange an interview please contact: Wendy Gerber, MSL, Email: wendy.gerber@mslworldwide.com, Phone: +44-7949-034-007